Bristol Myers Squibb Reports Second Quarter 2020 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/11/2026
- Wall St set to gain on tech rebound, Middle East in focus
- SpaceX prices historic IPO at $135/share in largest ever new listing
- Oil drops as Trump cancels planned strikes against Iran
- Intel rallies as BofA double-upgrades stock on increased CPU, foundry visibility
- Oppenheimer sees little strategic case for Tesla-SpaceX merger
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Needham Starts Hyliion Holdings (HYLN) at Buy
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
Bristol-Myers Squibb (BMY) Tops Q2 EPS by 15c, Updates FY EPS Guidance
August 6, 2020 7:00 AM EDTBristol-Myers Squibb (NYSE: BMY) reported Q2 EPS of $1.63, $0.15 better than the analyst estimate of $1.48. Revenue for the quarter came in at $10.1 billion versus the consensus estimate of $9.97 billion.
GUIDANCE:
Bristol-Myers Squibb sees FY2020 EPS of $6.10-$6.25, versus the consensus of $6.20.... More
